Paratek wins US contract to develop anthrax treatment

Paratek wins US contract to develop anthrax treatment

Source: 
BioPharma Dive
snippet: 

Paratek Pharmaceutical on Wednesday said it won a U.S. government contract worth as much as $285 million to develop its Nuzyra medicine for anthrax.